Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb, is seeking a Senior Scientist, Translational Medicine to support clinical biomarker strategy for our oncology portfolio. This hands-on role requires practical experience with biomarker sample handling, protocol design, and collaboration across translational teams.
You will work directly on oncology clinical studies, translate preclinical findings to clinical contexts, and help shape biomarker-driven decision making to accelerate
At RayzeBio, every day is an opportunity to ignite meaningful change. As a wholly-owned subsidiary of Bristol Myers Squibb, RayzeBio blends the nimble, pioneering spirit of an emergent biotech with the global expertise and resources of a leading innovator in oncology. Our mission is to develop transformative radiopharmaceutical therapies that offer new hope for patients living with cancer. Here, you’ll join a multidisciplinary team where your ideas are valued, your expertise is amplified, and collaboration is at the heart of everything we do. From day one, expect to make an immediate impact—on our science, on our teams, and most importantly, on patients. Learn more about RayzeBio: https://careers.bms.com/rayzebio/
RayzeBio is a dynamic biotechnology company headquartered in San Diego, CA. Launched in late 2020 and recently acquired by Bristol Myers Squibb (BMS) as a wholly owned subsidiary, the company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes. RayzeBio will operate as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology capabilities of BMS. RayzeBio is developing innovative drugs against targets of solid tumors. The lead asset, RYZ101, is in Phase 3 testing for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs), as well as earlier stage testing for patients with small cell lung cancer (SCLC). Led by a successful and experienced entrepreneurial team, RayzeBio aims to be the global leader in radiopharmaceuticals.
As a Senior Scientist, Translational Medicine supports clinical biomarker strategy for our oncology pipeline. This is an operationally focused, hands‑on role for a scientist who has already worked directly on oncology clinical studies and understands what it takes to get biomarker samples from protocol design